Results 181 to 190 of about 75,380 (266)

Cervical Anastomotic Leakage After Minimally Invasive McKeown Esophagectomy in the SAFER Surgical System: Clinical Course and Predictors of Delayed Healing

open access: yesThoracic Cancer, Volume 17, Issue 11, June 2026.
In a 517‐patient cohort, the SAFER surgical system was associated with predominantly low‐grade, manageable cervical anastomotic leakage after minimally invasive McKeown esophagectomy, with no ECCG grade III leakage or leak‐related mortality. POD1 serum albumin helped identify patients at risk of delayed healing. ABSTRACT Background Cervical anastomotic
Youyu Zhang   +11 more
wiley   +1 more source

Chronic hypoxia and mediastinal mass: think about a pulmonary artery to left atrial fistula! [PDF]

open access: yesJ Cardiol Cases
AbdelMassih AF   +5 more
europepmc   +1 more source

Adverse Drug Reaction Study of Botulinum Toxin‐A in the Real World

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Despite the increasing use of botulinum toxin type A (BoNT‐A) in aesthetic and therapeutic applications, its real‐world adverse drug reaction (ADR) profile remains incompletely characterized. Current evidence relies largely on small‐scale clinical observations rather than large, systematic analyses.
Jiaxu Gu   +9 more
wiley   +1 more source

Mediastinal Lymphoma in 70 Dogs Treated With Lomustine or Anthracycline‐Based Multi‐Agent Chemotherapy

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 2, Page 382-392, June 2026.
ABSTRACT Primary mediastinal lymphoma is rare in dogs and literature exploring this disease is limited. Therefore, the aim of this study was to describe presentation, treatment and outcome in a large cohort of dogs with mediastinal lymphoma and explore prognostic factors including chemotherapy protocol. This retrospective multi‐institute study included
Diogo Machado   +11 more
wiley   +1 more source

A Zosteriform Papular Cutaneous Eruption

open access: yes
JEADV Clinical Practice, Volume 5, Issue 2, Page 728-730, June 2026.
Silvia Borriello   +8 more
wiley   +1 more source

Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs

open access: yesVeterinary Dermatology, Volume 37, Issue 3, Page 419-426, June 2026.
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy